$0.6990
0.009001.30%
Pre-Market: 7:05 AM EDT
Comments
Loading...
Lexicon Pharmaceuticals (LXRX) Forecast
NewsEarningsLexicon Pharmaceuticals (LXRX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestLexicon Pharmaceuticals (NASDAQ:LXRX) Stock Quotes, Forecast and News Summary
Lexicon Pharmaceuticals Stock (NASDAQ: LXRX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Lexicon Pharmaceuticals (LXRX) stock?
You can purchase shares of Lexicon Pharmaceuticals (NASDAQ:LXRX) through any online brokerage.
Who are Lexicon Pharmaceuticals (LXRX) competitors?
Other companies in Lexicon Pharmaceuticals’s space includes: Voyager Therapeutics (NASDAQ:VYGR), Tango Therapeutics (NASDAQ:TNGX), Eledon Pharma (NASDAQ:ELDN), Anika Therapeutics (NASDAQ:ANIK) and aTyr Pharma (NASDAQ:ATYR).
What is the forecast, or price target, for Lexicon Pharmaceuticals (LXRX) stock?
Lexicon Pharmaceuticals has a consensus price target of $6.40.
What is the current price for Lexicon Pharmaceuticals (LXRX)?
The stock price for Lexicon Pharmaceuticals (NASDAQ: LXRX) is $0.699 last updated January 21, 2025 at 7:05 AM EST.
Does Lexicon Pharmaceuticals (LXRX) pay a dividend?
There are no upcoming dividends for Lexicon Pharmaceuticals.
When is Lexicon Pharmaceuticals (NASDAQ:LXRX) reporting earnings?
Lexicon Pharmaceuticals’s Q4 earnings are confirmed for Monday, March 10, 2025.
Is Lexicon Pharmaceuticals (LXRX) going to split?
There is no upcoming split for Lexicon Pharmaceuticals.
What sector and industry does Lexicon Pharmaceuticals (LXRX) operate in?
Lexicon Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.